Skip to main content
Top
Published in: European Spine Journal 3/2016

01-03-2016 | Original Article

Non-instrumented extradural lumbar spine surgery under low-dose acetylsalicylic acid: a comparative risk analysis study

Authors: Jehuda Soleman, Peter Baumgarten, Wolfgang Nicolas Perrig, Javier Fandino, Ali-Reza Fathi

Published in: European Spine Journal | Issue 3/2016

Login to get access

Abstract

Purpose

Coronary artery disease (CAD) affects over one-third of adults and is the leading cause of overall mortality and morbidity. Acetylsalicylic acid (ASA) is widely used in the prevention of CAD. As the population continues to mature, the number of patients presenting for spinal surgery that are under ASA treatment is rising. Studies investigating the outcome of lumbar spine surgeries without discontinuation of ASA therapy are lacking. The purpose of this study is to evaluate the peri- and postoperative bleeding and cardiovascular complication rates of patients undergoing non-instrumented, extradural, lumbar spine surgery with or without discontinuation of low-dose ASA.

Methods

We retrospectively compared the intra- and postoperative blood loss, morbidity, mortality, blood transfusion requirements and hematologic findings in the ASA group (40 patients) and the control group (62 patients). The diagnosis in all patients was either lumbar disc herniation or spinal canal stenosis.

Results

Intraoperative blood loss was 221 ml in the ASA group and 140.16 ml in the control group, showing no statistical difference (p = 0.08). Postoperative blood loss was 146.58 and 167.97 ml in the ASA and control groups, respectively, also without statistical difference (p = 0.76). In the ASA group one patient developed a postoperative epidural hematoma needing revision surgery, while in the control group no postoperative epidural hematomas were seen (p = 0.40). In addition, blood transfusion requirements, hematologic findings, morbidity and mortality showed no significant difference.

Conclusion

The continuation of ASA treatment in patients undergoing non-instrumented extradural lumbar spinal surgery seems to be safe and its perioperative continuation might therefore be recommended. Further studies confirming these results are needed.
Literature
5.
go back to reference Hennekens CH, Dyken ML, Fuster V (1997) Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 96:2751–2753CrossRefPubMed Hennekens CH, Dyken ML, Fuster V (1997) Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 96:2751–2753CrossRefPubMed
6.
go back to reference Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J (2000) The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy—a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 34:194–198CrossRefPubMed Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J (2000) The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy—a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 34:194–198CrossRefPubMed
8.
go back to reference Oscarsson A, Gupta A, Fredrikson M, Jarhult J, Nystrom M, Pettersson E, Darvish B, Krook H, Swahn E, Eintrei C (2010) To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 104:305–312. doi:10.1093/bja/aeq003 CrossRefPubMed Oscarsson A, Gupta A, Fredrikson M, Jarhult J, Nystrom M, Pettersson E, Darvish B, Krook H, Swahn E, Eintrei C (2010) To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 104:305–312. doi:10.​1093/​bja/​aeq003 CrossRefPubMed
10.
go back to reference Kumar R, McKinney WP, Raj G, Heudebert GR, Heller HJ, Koetting M, McIntire DD (2001) Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 16:507–518. pii:jgi00926 Kumar R, McKinney WP, Raj G, Heudebert GR, Heller HJ, Koetting M, McIntire DD (2001) Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 16:507–518. pii:jgi00926
11.
go back to reference Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med 257:399–414. pii:JIM1477 [pii]/j.1365-2796.2005.01477.x Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med 257:399–414. pii:JIM1477 [pii]/j.1365-2796.2005.01477.x
13.
go back to reference Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC Jr, Dekutoski MB, Bryant S (2000) Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine (Phila Pa 1976) 25:596–601 Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC Jr, Dekutoski MB, Bryant S (2000) Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine (Phila Pa 1976) 25:596–601
14.
go back to reference Park JH, Ahn Y, Choi BS, Choi KT, Lee K, Kim SH, Roh SW (2013) Antithrombotic effects of aspirin on 1- or 2-level lumbar spinal fusion surgery: a comparison between 2 groups discontinuing aspirin use before and after 7 days prior to surgery. Spine (Phila Pa 1976) 38:1561–1565. doi:10.1097/BRS.0b013e31829a84d2 CrossRef Park JH, Ahn Y, Choi BS, Choi KT, Lee K, Kim SH, Roh SW (2013) Antithrombotic effects of aspirin on 1- or 2-level lumbar spinal fusion surgery: a comparison between 2 groups discontinuing aspirin use before and after 7 days prior to surgery. Spine (Phila Pa 1976) 38:1561–1565. doi:10.​1097/​BRS.​0b013e31829a84d2​ CrossRef
15.
go back to reference Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849–1860. doi:10.1016/S0140-6736(09)60503-1 CrossRefPubMed Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849–1860. doi:10.​1016/​S0140-6736(09)60503-1 CrossRefPubMed
16.
go back to reference Hayden M, Pignone M, Phillips C, Mulrow C (2002) Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136:161-172. pii:200201150-00016 Hayden M, Pignone M, Phillips C, Mulrow C (2002) Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136:161-172. pii:200201150-00016
17.
go back to reference Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy—III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 308:235–246CrossRef Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy—III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 308:235–246CrossRef
18.
go back to reference Chassot PG, Marcucci C, Delabays A, Spahn DR (2010) Perioperative antiplatelet therapy. Am Fam Physician 82:1484-1489. pii:d8492 Chassot PG, Marcucci C, Delabays A, Spahn DR (2010) Perioperative antiplatelet therapy. Am Fam Physician 82:1484-1489. pii:d8492
19.
go back to reference Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K (2011) Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 105:743–749. doi:10.1160/TH10-04-0217 CrossRefPubMed Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K (2011) Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 105:743–749. doi:10.​1160/​TH10-04-0217 CrossRefPubMed
20.
go back to reference Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW (1998) Myocardial infarction after non-cardiac surgery. Anesthesiology 88:572–578CrossRefPubMed Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW (1998) Myocardial infarction after non-cardiac surgery. Anesthesiology 88:572–578CrossRefPubMed
21.
go back to reference Shah KB, Kleinman BS, Rao TL, Jacobs HK, Mestan K, Schaafsma M (1990) Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 70:240–247CrossRefPubMed Shah KB, Kleinman BS, Rao TL, Jacobs HK, Mestan K, Schaafsma M (1990) Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 70:240–247CrossRefPubMed
22.
go back to reference Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674. doi:10.1093/eurheartj/ehl334 CrossRefPubMed Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674. doi:10.​1093/​eurheartj/​ehl334 CrossRefPubMed
23.
go back to reference Beving H, Zhao C, Albage A, Ivert T (1996) Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 7:80–84CrossRefPubMed Beving H, Zhao C, Albage A, Ivert T (1996) Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 7:80–84CrossRefPubMed
24.
go back to reference Vial JH, McLeod LJ, Roberts MS (1991) Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal. Adv Prostaglandin Thromboxane Leukot Res 21A:157–160PubMed Vial JH, McLeod LJ, Roberts MS (1991) Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal. Adv Prostaglandin Thromboxane Leukot Res 21A:157–160PubMed
Metadata
Title
Non-instrumented extradural lumbar spine surgery under low-dose acetylsalicylic acid: a comparative risk analysis study
Authors
Jehuda Soleman
Peter Baumgarten
Wolfgang Nicolas Perrig
Javier Fandino
Ali-Reza Fathi
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
European Spine Journal / Issue 3/2016
Print ISSN: 0940-6719
Electronic ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-015-3864-7

Other articles of this Issue 3/2016

European Spine Journal 3/2016 Go to the issue